Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RIDA pseudogene 1 (RIDAP1) is a pseudogene, meaning it is a DNA sequence that resembles a protein-coding gene but is typically non-functional due to mutations or lack of regulatory elements required for expression. It is not known to encode an active protein, nor does it serve a recognized biological function as a therapeutic target, receptor, enzyme, transporter, or other typical drug target class[2][6][7]. The functional RIDA gene encodes an enzyme involved in mRNA catabolic processes and the hydrolytic deamination of enamine/imine intermediates[1][3][5]; however, RIDAP1 does not have such activity. Additional context: - Pseudogenes like RIDAP1 may occasionally have roles in gene regulation in some contexts (such as production of non-coding RNAs or acting as microRNA sponges), but no such function is reported or established for RIDAP1 specifically[2][4]. - Since it is not a functional protein, there are no known disease roles, biomarker uses, drug interactions, or therapeutic mechanisms for RIDAP1[2][6]. - This entry is considered incorrect as a therapeutic target because it is a pseudogene, not a protein-coding gene or druggable target[6][7]. Summary: RIDAP1 (RIDA pseudogene 1) is a pseudogene and does not correspond to an active molecular target for therapeutics, diagnostics, or biomarker applications. There is no evidence of function, disease involvement, or representational value as a canonical drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RIDA pseudogene 1 (RIDAP1).